Laminate Medical Technologies, Ltd.

Laminate Medical Technologies develops specialized medical devices for arteriovenous fistula (AVF) management in hemodialysis patients. The company's flagship product is the VasQ™ Extravascular Support, designed to improve AVF function and durability. VasQ™ received FDA Transitional Pass-Through (TPT) Payment designation as of October 2024, indicating recognition as a breakthrough technology offering clinically meaningful advantages for patients requiring renal replacement therapy. The device addresses a significant clinical need in the dialysis population, where AVF maturation failure and stenosis remain common complications. Laminate operates with a global focus on improving outcomes for hemodialysis-dependent patients worldwide.